News Home Page
Access the 15 most recent news items below. For older items, please click the 'view archives' link in the lower right.
BD Onclarity HPV Assay on the BD Viper LT System Achieves CE-IVD Mark
BD Diagnostics, a global medical technology company, has achieved CE/IVD marking for the BD Onclarity HPV Assay on the new BD Viper LT System.The BD Onclarity HPV Assay targets E6/E7 DNA oncogenes and is designed to provide physicians access to broader High Risk (HR) HPV genotype information beyond types 16 and 18 to guide informed treatment decisions for their patients. The BD Onclarity HPV Assay reports results on six discrete HR HPV genotypes (16, 18, 31, 45, 51 and 52) with the remaining eight ...
Posted on: March 07, 2014
UNITAID Report Highlights Lumora's Technology for Viral Load Monitoring for HIV
Lumora, a provider of molecular diagnostic products for the clinical and industrial market, has been named in the UNITAID HIV/AIDS Diagnostic Technology Report that highlights innovative new diagnostic technologies for viral load monitoring at or near the point of patient care.Lumora's HIV Viral Load BART (Bioluminescent Assay in Real Time) is due to be ready to transfer to a commercial partner during 2014 and aims to be one of the most inexpensive technologies on the market for assessing the viral load ...
Posted on: March 06, 2014
GenCell Changes the Library Prep Game with CLiC LP
The introduction of CLiC LP marks a new chapter for laboratories around the world involved with genetic sequencing. GenCell Biosystems has unveiled the world's first fully integrated, automated bench-top library prep workflow for next generation sequencing (NGS) that generates more data, quicker and at a lower cost.In addition to streamlining NGS library prep into a single instrument, CLiC LP leverages GenCell's patented Composite Liquid Cell (CLC) Technology, which was awarded the prestigious ...
Posted on: March 05, 2014
Myriad Genetics Data Shows Prolaris Predicts Metastases in Prostate Cancer from Biopsies
Myriad Genetics Data Shows Prolaris Predicts Metastases in Prostate Cancer from BiopsiesMyriad Genetics, Inc. announced it has published data in the Journal of Urology demonstrating that its Prolaris test accurately predicted, based on biopsy specimens, which men would develop biochemical recurrence (BCR) or metastatic disease following radical prostate surgery. Prolaris is a 46-gene molecular diagnostic test that has been evaluated in more than 5,000 patients across 11 clinical studies."This study ...
Posted on: March 04, 2014
Center for Phlebotomy Education Schedules Intensive 3-Day Seminars in Indianapolis, San Francisco
The Center for Phlebotomy Education is conducting an intensive 3-day seminars in Indianapolis and San Francisco this year for those who train or manage phlebotomists. The event will provide strategies to help attendees: Reduce expenses by cultivating satisfied, long-term employees Cut costs through process improvement Nurture professionalism and responsibility among specimen-collection personnel Implement different learning styles to maximize teaching Mentor students and new staff, and more. ...
Posted on: March 03, 2014
Greiner Bio-One presents innovative Cryo.s biobanking tubes
Greiner Bio-One, a technology partner for the diagnostic and pharmaceutical industry, will be presenting an innovative solution for storing biological samples in biorepositories, at Analytica 2014, April 1 to 4, in Munich,Germany.Greiner Bio-One has been developing and producing products for cryogenic storage for 30 years. With the new Cryo.s biobanking tubes, Greiner Bio-One is expanding its product portfolio to include a solution for high-throughput sample storage in automated storage systems. ...
Posted on: March 02, 2014
Lineagen Announces Identification of 39 Genetic Variants as Novel Risk Factors for Developing Autism Spectrum Disorder
Lineagen, a molecular diagnostics company focused on complex, genetically linked disorders, announced the publication of the first major study in autism spectrum disorder (ASD) to apply a unique research approach that identified 39 variants in 36 genes, which may confer a genetic risk of developing ASD. This approach - haplotype sharing in multi-generational families from the Utah Population Database (UPDB) - opens the door to more efficient elucidation of ASD gene risk variants and more ...
Posted on: February 28, 2014
PCL Alverno Clinical Labs and Beckman Coulter Diagnostics Partner to Innovate Laboratories to Better Serve Patients
With a strong commitment to advancing innovation in the clinical laboratory, PCL Alverno Clinical Laboratories awarded Beckman Coulter Diagnostics a new installation agreement. Processing more than 23 million tests per year, and dedicated to improving the quality of patient care, PCL Alverno was recently named a leader in innovation in Indiana and is the largest microbiology lab in the Midwest. PCL Alverno will modernize their laboratories with more than 150 new instruments beginning in 2014, implementing ...
Posted on: February 27, 2014
SLAS Announces 2014 JALA & JBS Art of Science Contest Winner
The Society for Laboratory Automation and Screening (SLAS) announces that Tomasz Koprowski of the Institute for Chemical and Bioengineering in Zurich, Switzerland, is the grand prize winner of the 2014 JALA & JBS Art of Science Contest.Nine finalists from six countries were selected from 60 entries. SLAS members and nonmembers then voted for their favorite finalists at SLAS.org. "Tree of Life" by Tomasz Koprowski captures C.elegans worms on a chunk of agar and as the top vote-getter and grand ...
Posted on: February 26, 2014
Change in Guidelines for Type 2 Diabetes Screening Tests May Lead to Under-Diagnosis in Children
New American Diabetes Association (ADA) screening guidelines may lead to the missed diagnoses of type 2 diabetes in children, according to a new study by University of Michigan.The research, published in the Journal of Adolescent Health, finds that both pediatric and family medicine providers who care for children are using screening tests for type 2 diabetes that may result in missed diagnoses for children, says lead author Joyce Lee, MD, MPH, associate professor in U-M's Departments of Pediatrics ...
Posted on: February 25, 2014
Superbug: Hypervirulent KPC Created In Lab, Reported In Nature
Highly virulent and nearly completely resistant to antibiotics, a pathogen that occurred in nature at least once and created with shocking ease in the lab poses a "catastrophic threat" to the U.S. health care system, the lead investigator of the research tells Hospital Infection Control & Prevention."This conjugated strain killed [lab] mice really quickly, plus being almost pan-resistant to all antibiotics at that point," says Tom Chiang, MD, an assistant professor at Rutgers University and infectious ...
Posted on: February 24, 2014
Horizon Discovery Launches GENASSIST Line of Kits and Reagents for Gene-Editing
Horizon Discovery (Horizon), a provider of research tools to support translational genomics and the development of personalized medicines, today announced it has launched the first products and services from its new GENASSIST range of gene editing kits and reagents that enable easier, robust implementation of CRISPR and rAAV gene editing experiments.The current GENASSIST offering comprises both off-the-shelf reagents for using CRISPR editing technology and a unique kit combination of these reagents to ...
Posted on: February 23, 2014
Distribution Agreement Between Microgen Bioproducts and Quidel Expanded
Lab21, a global specialist in personalized medicine and clinical diagnostics, has expanded its existing agreement with Quidel Corporation, through its subsidiary, Microgen Bioproducts Limited. The expanded agreement will see Lab21 distribute AnDiaTec's Real-Time PCR Tests within the United Kingdom. This expands on the previous agreement which has seen Lab21 distribute the QuickVue product range in the UK.The AnDiaTec product range includes tests that aid in the diagnosis of several infectious ...
Posted on: February 21, 2014
EHR-Based Screening Program for Abdominal Aortic Aneurysms Cuts the Number of Unscreened At-Risk Men by More than Half
A screening program for abdominal aortic aneurysms, integrated into an electronic health record, dramatically reduced the number of unscreened at-risk men by more than 50 percent within 15 months, according to a Kaiser Permanente study published in the Journal of Vascular Surgery. An abdominal aortic aneurysm is a balloon-like bulge in the aorta, which -- if ruptured -- can result in death. It is estimated that more than one million Americans are living with undiagnosed AAA, according to the ...
Posted on: February 20, 2014